UCLA study links SARS‑CoV‑2 nucleocapsid protein to immune overdrive

Scientists are still discovering how SARS‑CoV‑2 can damage the body, even six years after the pandemic’s peak. A recent study from the University of California, Los Angeles, published in *Science Advances*, reveals a new mechanism by which the virus’s nucleocapsid protein—an internal structural component less publicized than the spike protein—can trigger an excessive immune response.

The research shows that the nucleocapsid protein binds to specific immune receptors, leading to heightened production of inflammatory molecules. This overactivation can contribute to severe complications such as cytokine storms, which have been linked to organ failure in COVID‑19 patients. The findings add to a growing body of evidence that non‑spike viral proteins play critical roles in disease progression and may inform future therapeutic strategies.

These insights underscore the importance of studying all viral components, not just the spike protein, to fully understand COVID‑19’s long‑term health effects. The UCLA team’s work may help guide the development of treatments aimed at moderating the immune system’s response to the virus.